Bovine islets are less susceptible than human islets to damage by human cytokines

被引:23
作者
Piro, S
Lupi, R
Dotta, F
Patanè, G
Rabuazzo, MA
Marselli, L
Santangelo, C
Realacci, M
Del Guerra, S
Purrello, F
Marchetti, P
机构
[1] Univ Catania, Cattedra Endocrinol & Patol Costituz, I-95124 Catania, Italy
[2] Univ Pisa, Dipartimento Endocrinol & Metab, Sez Metab, I-56100 Pisa, Italy
[3] Univ La Sapienza, Dipartimento Sci Clin, Rome, Italy
关键词
D O I
10.1097/00007890-200101150-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background The potential benefits of islet xenografting in type 1 diabetes include the intriguing, but still unanswered, possibility that the grafted xeno-islets may be less subjected to human autoimmune attack. Cytokines may play a major role in the pathogenesis of autoimmune diabetes by causing impairment of insulin release and pancreatic islet cell toxicity. Methods. We compared insulin secretion, islet cell death and survival, inducible nitric oxide synthase (iNOS) mRNA expression, nitrite production, and Bcl-2 and Bax mRNA expression in isolated human and large mammal (bovine) islets exposed to 50 U/ml recombinant human interleukin-1, 1000 U/ml recombinant human tumor necrosis factor-alpha and 1000 U/ml recombinant human interferon-gamma, Results. After 24-hr exposure, a marked decrease of glucose-stimulated insulin secretion was observed with human, but not with bovine islets, After 48-hr exposure, human, but not bovine, pancreatic islets showed a significantly higher percentage of apoptotic cells compared to controls. Treatment of human islets with human cytokines induced up-regulation of iNOS mRNA, increased levels of nitrites, and down-regulation of Bcl-2 mRNA, with unchanged levels of Bax mRNA These parameters were not affected by cytokines in bovine islets, Conclusions, Bovine islets are less susceptible than human islets to the effects of human cytokines, which may be a potential advantage of xenotransplantation.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 40 条
[1]   Long-term function (6 years) of islet allografts in type 1 diabetes [J].
Alejandro, R ;
Lehmann, R ;
Ricordi, C ;
Kenyon, NS ;
Angelico, MC ;
Burke, G ;
Esquenazi, V ;
Nery, J ;
Betancourt, AE ;
Kong, SS ;
Miller, J ;
Mintz, DH .
DIABETES, 1997, 46 (12) :1983-1989
[2]   Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors [J].
Armstrong, RC ;
Aja, T ;
Xiang, JL ;
Gaur, S ;
Krebs, JF ;
Hoang, K ;
Bai, X ;
Korsmeyer, J ;
Karanewsky, DS ;
Fritz, LC ;
Tomaselli, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16850-16855
[3]  
Boersma AWM, 1996, CYTOMETRY, V24, P123, DOI 10.1002/(SICI)1097-0320(19960601)24:2<123::AID-CYTO4>3.0.CO
[4]  
2-K
[5]   Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM [J].
Calafiore, R .
DIABETES CARE, 1997, 20 (05) :889-896
[6]   NITRIC-OXIDE MEDIATES CYTOKINE-INDUCED INHIBITION OF INSULIN-SECRETION BY HUMAN ISLETS OF LANGERHANS [J].
CORBETT, JA ;
SWEETLAND, MA ;
WANG, JL ;
LANCASTER, JR ;
MCDANIEL, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1731-1735
[7]  
Del Guerra S, 2000, DIABETES-METAB RES, V16, P281, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR124>3.0.CO
[8]  
2-Q
[9]   Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells [J].
Delaney, CA ;
Pavlovic, D ;
Hoorens, A ;
Pipeleers, DG ;
Eizirik, DL .
ENDOCRINOLOGY, 1997, 138 (06) :2610-2614
[10]  
Di Mario U, 1998, DIABETES METAB REV, V14, P1, DOI 10.1002/(SICI)1099-0895(199803)14:1<1::AID-DMR202>3.0.CO